Category:Immunosuppressive monoclonal antibodies
Revision as of 21:11, 27 February 2020 by Warner-admin (talk | contribs) (Created page with "A class of monoclonal antibodies intended to cause an immunosuppressant effect. This can be a primary intended effect or a side effect of treatment (e.g., the use of rituximab...")
A class of monoclonal antibodies intended to cause an immunosuppressant effect. This can be a primary intended effect or a side effect of treatment (e.g., the use of rituximab in malignancy will have a side effect of immunosuppression).
Subcategories
This category has the following 9 subcategories, out of 9 total.